SS-31 (Elamipretide) vs Urolithin A

Overview

SS-31 (Elamipretide) and Urolithin A are both anti-aging & longevity peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares SS-31 (Elamipretide) and Urolithin A across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. SS-31 (Elamipretide) is categorised under Anti-aging & Longevity, while Urolithin A falls under Anti-aging & Longevity. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. SS-31 (Elamipretide): not FDA-approved; treated as a research compound. Urolithin A: not FDA-approved; treated as a research compound.

Dosing. SS-31 (Elamipretide) is typically dosed at Clinical trials ongoing (research). Urolithin A is typically dosed at 250-500 mg (daily).

Can you stack them?

Some protocols combine peptides, but stacking SS-31 (Elamipretide) and Urolithin A has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between SS-31 (Elamipretide) and Urolithin A?

SS-31 (Elamipretide) and Urolithin A are both anti-aging & longevity peptides, but they differ in mechanism, dosing, and regulatory status. SS-31 (Elamipretide) is not FDA-approved; generally classified as a research compound, whereas Urolithin A is not FDA-approved; generally classified as a research compound.

What is SS-31 (Elamipretide) used for?

Mitochondrial optimization.

What is Urolithin A used for?

Mitochondrial health compound.

Can you take SS-31 (Elamipretide) and Urolithin A together?

Some users combine peptides within a single protocol, but stacking SS-31 (Elamipretide) and Urolithin A has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is SS-31 (Elamipretide) or Urolithin A FDA-approved?

SS-31 (Elamipretide) is not FDA-approved; generally classified as a research compound. Urolithin A is not FDA-approved; generally classified as a research compound.